The differential expressions of C1QA, C1QB and C1QC were found to be closely related to the survival prognosis, pathological features, and tumor microenvironment of osteosarcoma, which can help improve the clinical prognosis and immunotherapy [31]. This evidence concerns the gene C1QC and osteosarcoma.